Clinical Trials Logo
  1. Home
  2. Hepatitis b Vaccine
  3. NCT02991599

Immunogenicity of Hepatitis B Vaccination in Methadone Maintenance Treatment Patients

Hepatitis B Vaccine Clinical Trial

Official title:
Immunogenicity and Persistence of Intramuscular High Dose Recombinant Hepatitis B Vaccine in Methadone Maintenance Treatment Patients in China: a Randomized Controlled Trial

Clinical Trial Summary

This is a randomized, controlled trial. The study will evaluate the immunogenicity, immune persistence, and safety of 20 µg and 60 µg recombinant hepatitis B vaccine with three injections at months 0, 1, and 6 in methadone maintenance treatment patients.

Clinical Trial Description

Comparison of 2 vaccination strategy against Hepatitis B in patients with Methadone Maintenance Treatment Intervention: Arm 1 : 60 µg recombinant hepatitis B vaccine with three injections at months 0, 1, and 6; Arm 2 : 20 µg recombinant hepatitis B vaccine with three injections at months 0, 1, and 6. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02991599
Study type Interventional
Source Shanxi Medical University
Contact
Status Completed
Phase Phase 4
Start date October 2014
Completion date May 2018
View Details
See also
  Status Clinical Trial Phase
Completed NCT03316807 - Immunogenicity of Hepatitis B Vaccination in HIV-infected Adults Phase 4
Completed NCT02901951 - Long-term Persistence of Immunity to Hepatitis B in Adults Vaccinated With GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine (HBV), Engerix-B Phase 4
Not yet recruiting NCT03962816 - Immunogenicity and Persistence of Hepatitis B Vaccination in Methadone Maintenance Treatment Patients Phase 4
Not yet recruiting NCT03962881 - Research on Optimal Immunization Strategy of Hepatitis B Vaccine in Chronic Kidney Disease Population Phase 4
Not yet recruiting NCT03962803 - Immunogenicity and Persistence of Hepatitis B Vaccination in HIV-Infected Patients Phase 4
Completed NCT02432430 - Comparison of Immunization Quality Improvement Dissemination Study N/A
Not yet recruiting NCT05099757 - The Immunogenicity and Persistence of Booster Dose With Hepatitis B Vaccine in College Students Phase 4
Completed NCT02963714 - Immunogenicity of Hepatitis B Vaccination in Hemodialysis Patients Phase 4
Recruiting NCT01590381 - Assessment of HBV Vaccine Immunity After 18 Years N/A
Completed NCT00519649 - Long-term Persistence of Immunity Against Hepatitis B in 7-8 Years Old Children After Hepatitis B Vaccination. Phase 4